featured
Benefits and Harms of Omalizumab Treatment in Adolescent and Adult Patients With Chronic Idiopathic (Spontaneous) Urticaria
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Benefits and Harms of Omalizumab Treatment in Adolescent and Adult Patients With Chronic Idiopathic (Spontaneous) Urticaria: A Meta-Analysis of "Real-World" Evidence
JAMA Dermatol 2018 Nov 14;[EPub Ahead of Print], MD Tharp, JA Bernstein, A Kavati, B Ortiz, K MacDonald, K Denhaerynck, I Abraham, CS LeeFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.